Core Viewpoint - Shanghai Aiwei Electronics Technology Co., Ltd. is undergoing adjustments to its 2022 Restricted Stock Incentive Plan, including the cancellation of unvested shares and changes to the grant price and quantity of shares [4][9][10]. Group 1: Legal Opinions and Approvals - The law firm has confirmed that the necessary legal procedures for the cancellation, adjustment, and vesting of shares have been completed in accordance with relevant laws and regulations [4][12]. - The company has received approval from its board and supervisory board for the adjustments to the incentive plan, including the authorization to manage and adjust the plan [7][9][10]. Group 2: Adjustments to the Incentive Plan - The initial grant price of the restricted stock has been adjusted from RMB 53.07 per share to RMB 37.97 per share, and the number of shares granted has increased from 4.78 million to approximately 6.68 million shares [9][10]. - A total of 418,713 shares that were granted but not vested have been canceled due to various reasons, including employee departures and performance assessments [11][12]. Group 3: Vesting Conditions - The vesting conditions for the second vesting period of the incentive plan have been met, allowing for the vesting of shares for 437 eligible participants [19][21]. - The performance metrics for the second vesting period are based on revenue growth, with specific thresholds set for the company’s performance [18][19].

Core Viewpoint - The company has conducted a review of its 2025 Restricted Stock Incentive Plan draft, confirming its eligibility and compliance with relevant laws and regulations [1][2][4]. Group 1: Eligibility and Compliance - The company meets the qualifications to implement the incentive plan, having no negative audit opinions or internal control issues in the last fiscal year [2][3]. - The incentive plan does not include independent directors or shareholders holding more than 5% of the company's shares, aligning with regulatory requirements [3][4]. - The review process and content of the incentive plan comply with the Company Law, Securities Law, and other relevant regulations [4]. Group 2: Implementation Process - The company will publicly disclose the names and positions of the incentive plan participants for at least 10 days before the shareholders' meeting [3][4]. - The board's remuneration and assessment committee will provide feedback on the participant list five days prior to the shareholders' meeting [4]. - The implementation of the incentive plan is subject to approval by the shareholders' meeting [4].

北京市天元律师事务所 关于安徽华骐环保科技股份有限公司 法律意见书 北京市天元律师事务所 北京市西城区金融大街 35 号 国际企业大厦 A 座 509 单元 邮编：100033 北京市天元律师事务所 关于安徽华骐环保科技股份有限公司 法律意见书 京天股字（2025）第 276 号 致：安徽华骐环保科技股份有限公司 根据北京市天元律师事务所（以下简称"本所"）与安徽华骐环保科技股份 有限公司（以下简称"华骐环保"或"公司"）签订的《专项法律服务协议》， 本所担任公司本激励计划的专项中国法律顾问并出具法律意见。 本所及经办律师依据《中华人民共和国公司法》（以下简称《公司法》）、 《中华人民共和国证券法》（以下简称《证券法》）、《上市公司股权激励管理 办法》（以下简称《管理办法》）、《深圳证券交易所创业板股票上市规则》 （以 下简称《上市规则》）、《律师事务所从事证券法律业务管理办法》《律师事务 所证券法律业务执业规则（试行）》等规定及本法律意见书出具日以前已经发生 或者存在的事实，按照律师行业公认的业务标准、道德规范和勤勉尽责的精神， 出具本法律意见书。 为出具本法律意见书，本所律师审阅了公司拟订的《安徽华骐环保 ...

创业板上市公司股权激励计划自查表 公司简称：华骐环保 股票代码：300929 独立财务顾问：上海荣正企业咨询服务（集团）股份有限公司 是否存在该 序号 事项 事项（是/否/ 备注 上市公司合规性要求 最近一个会计年度财务会计报告是否被注册会计师出具否定意 见或者无法表示意见的审计报告 最近一个会计年度财务报告内部控制被注册会计师出具否定意 见或者无法表示意见的审计报告 上市后最近 36 个月内出现过未按法律法规、公司章程、公开承 诺进行利润分配的情形 激励对象合规性要求 是否包括单独或者合计持有上市公司 5%以上股份的股东或者 明前述人员成为激励对象的必要性、合理性 最近 12 个月内因重大违法违规行为被中国证监会及其派出机 构行政处罚或者采取市场禁入措施 是否具有《公司法》规定的不得担任公司董事、高级管理人员情 形 激励计划合规性要求 上市公司全部在有效期内的股权激励计划所涉及的标的股票总 数累计是否超过公司股本总额的 20% 激励对象预留权益比例是否未超过本次股权激励计划拟授予权 益数量的 20% 激励对象为董事、高级管理人员、单独或合计持股 5%以上股东 计划草案是否已列明其姓名、职务、获授数量 激励对 ...

证券代码：603286 证券简称：日盈电子 公告编号：2025-047 江苏日盈电子股份有限公司 关于 2024 年限制性股票与股票期权激励计划 股票期权第一个行权期行权结果暨股份上市公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ? 本次股票上市类型为股权激励股份；股票认购方式为网下，上 市股数为432,000股。 本次股票上市流通总数为432,000股。 ? 本次股票上市流通日期为2025 年 6 月 6 日。 一、本次 2024 年限制性股票与股票期权激励计划股票期权行权的决策程序及 相关信息披露 于 <江苏日盈电子股份有限公司 ensp="ensp" 年限制性股票与股票期权激励计划="年限制性股票与股票 期权激励计划" 草案="草案"> 及其摘要的议案》《关于 <江苏日盈电子股份有限公司 ensp="ensp" 年限制性股票与股票="年限制性股 票与股票"> 期权激励计划实施考核管理办法>的议案》《关于提请公司股东大会授权董事会办 理 2024 年限制性股票与股票期权激励计划相关事宜的议案》等 ...

Core Points - The Supervisory Board of Beijing YH Tech Co., Ltd. has reviewed and approved the list of incentive recipients for the 2025 restricted stock incentive plan [1][2] - The granting date is set for May 30, 2025, with a grant price of 24.00 yuan per share, totaling 395,000 restricted shares to be awarded to 38 eligible recipients [2] Summary by Categories - **Eligibility Criteria**: The Supervisory Board confirmed that the incentive recipients meet the qualifications outlined in relevant laws and regulations, including the Company Law, Securities Law, and the Management Measures for Equity Incentives [1][2] - **Ineligible Conditions**: The document specifies conditions under which individuals are deemed ineligible for the incentive plan, including being recognized as inappropriate candidates by the stock exchange or the China Securities Regulatory Commission (CSRC) within the last 12 months [1] - **Approval Process**: The Supervisory Board has agreed to the list of incentive recipients, affirming that their qualifications are legal and valid according to the company's incentive plan draft [2]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002773 证券简称：康弘药业 公告编号：2025-025 成都康弘药业集团股份有限公司 第八届董事会第十一次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 一、董事会会议召开情况 成都康弘药业集团股份有限公司（以下简称"公司"）第八届董事会第十一次会议于2025年5月29日在公 司会议室通过现场和通讯相结合的方式召开。会议通知已于2025年5月24日以书面、传真或电子邮件等 形式向所有董事发出。本次董事会应到董事九名，实到董事九名（其中：董事王霖先生、张志荣先生， 独立董事周德敏先生、邓宏光先生、许楠女士以通讯方式参加），会议由董事长柯尊洪先生主持，公司 监事、董事会秘书及部分高级管理人员列席了会议。本次会议的召开符合《中华人民共和国公司法》和 《成都康弘药业集团股份有限公司章程》的有关规定。 二、董事会会议审议情况 关联董事柯尊洪先生、柯潇先生、钟建荣女士、殷劲群先生回避本议案的表决。 根据公司《2021年股票期权激励计划（草案）》的相关规定及股东大会的授权，结合公司二〇二四年度 ...

Company Overview - Hunan Haili Chemical Co., Ltd. is a leading enterprise in the manufacturing of chemical raw materials and products, primarily focusing on pesticide raw materials, formulations, intermediates, and lithium battery materials [1] - The company has over 70 years of experience in chemical research and development, holding a dominant position in the domestic market for carbamate pesticides with a high market share and self-sufficient key raw materials [1] - Hunan Haili is recognized as a major center for pesticide innovation and research in China, hosting several national research centers and maintaining a leading position in various pesticide-related research areas [1] Recent Performance - The company's operating revenue for the last three years was reported as follows: 2021: 2,470.84 million CNY, 2020: 2,374.35 million CNY, and 2019: 3,130.11 million CNY [3] - Research and development (R&D) investment has shown fluctuations, with 2021 at 142.56 million CNY, 2020 at 121.80 million CNY, and 2019 at 145.94 million CNY, reflecting a growth rate of 17.04% in 2021 and a decline of 16.54% in 2020 [3] - Net profit figures were 288.53 million CNY in 2021, 283.93 million CNY in 2020, and 374.46 million CNY in 2019, with a notable increase in net profit attributable to shareholders after excluding non-recurring gains and losses [3] Stock Incentive Plan - The company plans to grant 16.76 million restricted stocks, accounting for 3.00% of the total share capital, with 97.14% of these being initial grants [4][6] - The initial grant price for the restricted stocks is set at 3.47 CNY per share, which is below the average trading price prior to the announcement [11] - The incentive plan aims to enhance the company's governance structure, motivate key personnel, and align the interests of shareholders and employees [5][6] Performance Targets - The performance targets for the incentive plan include achieving a net profit growth rate of at least 45% by 2025, with additional targets for net asset return and revenue growth [18][19] - The plan includes annual performance assessments to determine the release of restrictions on the granted stocks, with specific growth rates set for each year from 2025 to 2027 [18][19] Governance and Compliance - The company has established a comprehensive governance framework for the stock incentive plan, including the requirement for independent legal and financial opinions [25][26] - The plan stipulates conditions under which the granted stocks may be revoked or adjusted, ensuring compliance with relevant laws and regulations [27][28]

（1）最近一个会计年度财务会计报告被注册会计师出具否定意见或者无法表 示意见的审计报告； （2）最近一个会计年度财务报告内部控制被注册会计师出具否定意见或无法 表示意见的审计报告； （3）上市后最近 36 个月内出现过未按法律法规、《公司章程》、公开承诺 进行利润分配的情形； （4）法律法规规定不得实行股权激励的； 湖南海利化工股份有限公司 董事会薪酬与考核委员会 关于公司 2025 年限制性股票激励计划（草案修订稿）及首次 授予激励对象名单的核查意见 湖南海利化工股份有限公司（以下简称"公司"）薪酬与考核委员会依据 《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人民共和国证 券法》（以下简称"《证券法》"）、《上市公司股权激励管理办法》（以下简 称"《管理办法》"）、《国有控股上市公司（境内）实施股权激励试行办法》 和《关于规范国有控股上市公司实施股权激励制度有关问题的通知》等相关法律、 法规及规范性文件和《湖南海利化工股份有限公司章程》（以下简称"《公司章 程》"）的有关规定，对公司《2025 年限制性股票激励计划（草案修订稿）》 （以下简称"本次激励计划"）及其他相关资料进行了核查，发表核查 ...

Core Viewpoint - The company has decided to repurchase and cancel 269,500 restricted stocks from its 2023 incentive plan due to the departure of certain incentive recipients and unsatisfactory performance evaluations [1][2]. Summary by Sections Decision and Disclosure - The decision to repurchase and cancel the restricted stocks was approved during the board meeting on October 21, 2024, and the first extraordinary shareholders' meeting on February 27, 2025 [1]. - The repurchase price is set at 4.10 yuan per share, and the company has applied for the cancellation of these stocks with the China Securities Depository and Clearing Corporation [1][2]. Repurchase and Cancellation Details - The repurchase is based on the company's 2023 incentive plan, which stipulates that stocks cannot be released from restrictions if the recipients leave the company or fail to meet performance criteria [2]. - A total of 10 individuals, including middle management and key personnel, are involved in this repurchase, resulting in a total of 269,500 shares being canceled [2][3]. Impact on Share Structure - Following the cancellation, the total number of restricted shares will decrease to 2,363,550, and the overall share count will reduce by 269,500 shares [3][5]. Compliance and Commitments - The board assures that the repurchase and cancellation process complies with relevant laws and regulations, and it will not adversely affect the company's operations [4][6]. - The company has confirmed the accuracy and completeness of the information regarding the repurchase and has communicated this to the relevant incentive recipients [6].